Related references
Note: Only part of the references are listed.Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer
Yawei Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research
Maneesh Kumarsing Beeharry et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models
Qitian Chen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis
Xunlei Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Progress of preoperative and postoperative radiotherapy in gastric cancer
Nan Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Mortality differences by surgical volume among patients with stomach cancer: a threshold for a favorable volume-outcome relationship
Hyeok Choi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Prognostic factors in patients with loco-regionally advanced gastric cancer
Bo Hultman et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
The patterns and timing of recurrence after curative resection for gastric cancer in China
Dan Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis
Meng-long Zhou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Adjuvant treatments for gastric cancer: From practice guidelines to clinical practice
Anne Marie Bouvier et al.
DIGESTIVE AND LIVER DISEASE (2014)
Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after RO Surgical Resection: A Meta-Analysis of Randomized Trials
Christine Min et al.
ONCOLOGY (2014)
Clinical Outcomes for Gastric Cancer following Adjuvant Chemoradiation Utilizing Intensity Modulated versus Three-Dimensional Conformal Radiotherapy
Gene-Fu F. Liu et al.
PLOS ONE (2014)
Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection
Tae Hyun Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection
Wei-guo Zhu et al.
RADIOTHERAPY AND ONCOLOGY (2012)
The role of perioperative radiotherapy in gastric cancer
Thales Paulo Batista et al.
ONCOLOGY REVIEWS (2012)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
Adjuvant therapy for resected gastric cancer-rapid, yet incomplete adoption following results of intergroup 0116 trial
Natalie G. Coburn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The survival impact of the intergroup 0116 trial on patients with gastric cancer
Kevin R. Kozak et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
S Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer
HH Hartgrink et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Timing of death from tumor recurrence after curative gastrectomy for gastric cancer
B Sakar et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial
HH Hartgrink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prospective study of peritoneal recurrence after curative surgery for gastric cancer
F Roviello et al.
BRITISH JOURNAL OF SURGERY (2003)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer
Y Maehara et al.
BRITISH JOURNAL OF SURGERY (2000)
Share Paper
